Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently FDA-approved for four diseases but widely prescribed off-label to treat more than 80 additional ones because it’s often the only medicine that has any impact on these conditions.
This article was originally published on MedicalXpress.com

